We Pharma, Inc.
Morrisville, NC Doing business as WEP Clinical
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 951 Aviation Pkwy #200, Morrisville, NC 27560, USA
- Website
- wepclinical.com
- Founded
- 2008
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 89 Services, Not Elsewhere Classified
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $873,614 |
| FY2025 | $971,817 |
| FY2024 | $834,944 |
| FY2023 | $1,320,240 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $873,614 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Astor Drugs | Holtsville, NY | 325412 Pharmaceutical Preparation Manufacturing |
| ADC Therapeutics America, Inc. | New Providence, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Exela Pharma Sciences LLC | Lenoir, NC | 325412 Pharmaceutical Preparation Manufacturing |
| Amerisourcebergen | Conshohocken, PA | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
About the company
We Pharma, Inc., doing business as WEP Clinical, is a corporate entity registered in SAM.gov since April 2015, structured as a self-certified small disadvantaged business and limited liability company located in Morrisville, North Carolina. The company specializes in providing pharmaceutical drug products and related services to federal agencies, with a primary focus on supporting research, regulatory, and operational needs of government health institutions. While specific details about the company's internal operations are not provided, its federal contract history demonstrates a consistent capability to supply pharmaceutical products to critical government research and regulatory programs.
We Pharma, Inc. has exclusively provided pharmaceutical products to the Food and Drug Administration (FDA) through multiple federal contract awards. These contracts have been non-set-aside delivery orders focused on supplying currently marketed drug products to support various FDA research initiatives, including the Generic Drug User Fee Amendments (GDUFA) regulatory science program and the Office of Pharmaceutical Quality Research (OPQR). The contract awards have ranged from $100,000 to $2,000,000, consistently targeting domestic pharmaceutical manufacturing, regulatory purposes, and emergency delivery services. Each contract has been awarded as a firm-fixed-price delivery order, with no specific set-aside designations, indicating the company's ability to compete effectively in open federal procurement processes.
We Pharma, Inc. holds two significant Indefinite Delivery Contracts (IDVs) with the FDA, one awarded in September 2020 with a $9.5 million ceiling and another in June 2021 with a $6 million ceiling. These IDVs are single-award contracts that enable the company to provide pharmaceutical products and emergency overnight delivery services supporting FDA research, regulatory, and operational activities through August 2026. The contracts require We Pharma to maintain a pharmaceutical pricing list updated annually and provide emergency delivery capabilities. Task orders under these IDVs have supported various FDA offices, including locations in Silver Spring, Maryland, and St. Louis, Missouri, demonstrating the company's nationwide service capabilities in supporting critical government pharmaceutical research and regulatory needs.
SBA capabilities narrative
We Pharma specialize in supplying a wide range of pharmaceutical products to our customers in the most expeditious, cost effective manner possible. We are fully licensed, and have many years of experience in the pharmaceutical industry.
WE Pharma is a Specialty Pharmaceutical Distributor. This means we have relationships and access to products (Brand and Generic) from manufacturers and wholesalers. We work with these manufacturers and wholesalers directly in order to find the right product at the right price to ensure our customers the best value for their money.
Quick answers
Is We Pharma, Inc. registered in SAM.gov?
Yes. We Pharma, Inc.'s SAM.gov registration is active through November 4, 2026.
What is We Pharma, Inc.'s CAGE code?
We Pharma, Inc.'s CAGE code is 7CN54, and its Unique Entity ID (UEI) is EWAMVJSFNK29.
How much has We Pharma, Inc. received in federal contracts?
Federal contracts obligated $971,817 to We Pharma, Inc. in fiscal year 2025 and $4,000,615 in fiscal years 2023 through 2027.
How does We Pharma, Inc. rank among federal contractors?
We Pharma, Inc. ranked #5 in NAICS 4242 and #26 in NAICS 424 in FY2025.
What is We Pharma, Inc.'s most recent federal award?
We Pharma, Inc.'s most recent federal contract award is Pharmaceutical drug products - to obtain source or sources of currently marketed drugs products for FDA research… (75F40125F19011), from Food and Drug Administration, on September 16, 2025.
On GovTribe
See We Pharma, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors